Skip to the page

Data / Drug companies / Bausch Health US LLC

Bausch Health US LLC: 76 products in the FDA NDC directory, labeler code 0187

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Bausch Health US LLC (labeler code 0187) lists 76 products in the FDA National Drug Code Directory, covering 33 finished drugs by generic name. By type: 73 prescription drugs, 3 over the counter drugs. Its main marketing category is new drug applications (NDA). The newest product started marketing on October 20, 2023.

The request: Watch Bausch Health US LLC (FDA labeler code 0187): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
0187
Products in commercial distribution
76
Packages
129
Finished drugs by generic name
33
Prescription products
73
Over the counter products
3
Controlled substance products
Schedule IV 3
Flagged as original packager
75 of 75 products that carry the flag
Started marketing in the last 12 months
0
Products with a marketing end date set
3
Earliest marketing start
April 6, 1955
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
New drug applications (NDA)7092.1%
Over the counter monograph drugs33.9%
Generic drugs (ANDA)22.6%
Biologics (BLA)11.3%

Products by type

TypeProductsShare
Prescription drugs7396.1%
Over the counter drugs33.9%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet, extended release1215.8%
Tablet911.8%
Cream911.8%
Gel911.8%
Lotion79.2%
Capsule, extended release67.9%
Capsule, coated, extended release56.6%
Capsule45.3%
Tablet, coated33.9%
Tablet, film coated33.9%
Solution22.6%
Tablet, orally disintegrating11.3%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Cabtreo0187-0006GelNew drug applications (NDA)October 20, 2023
Arazlo0187-2098LotionNew drug applications (NDA)December 19, 2019
Tetracaine Hydrochloride0187-0920Solution/ dropsNew drug applications (NDA)June 27, 2019
Duobrii0187-0653LotionNew drug applications (NDA)April 25, 2019
Bryhali0187-0002LotionNew drug applications (NDA)November 6, 2018
Altreno0187-0005LotionNew drug applications (NDA)August 24, 2018
Retin-A MICRO0187-5146GelNew drug applications (NDA)October 23, 2017
Siliq0187-0004InjectionBiologics (BLA)February 15, 2017
Onexton0187-3050GelNew drug applications (NDA)November 24, 2014
Tiazac extended release0187-2617Capsule, extended releaseNew drug applications (NDA)August 20, 2014
Tiazac extended release0187-2616Capsule, extended releaseNew drug applications (NDA)August 20, 2014
Tiazac extended release0187-2615Capsule, extended releaseNew drug applications (NDA)August 20, 2014
Tiazac extended release0187-2614Capsule, extended releaseNew drug applications (NDA)August 20, 2014
Tiazac extended release0187-2613Capsule, extended releaseNew drug applications (NDA)August 20, 2014
Tiazac extended release0187-2612Capsule, extended releaseNew drug applications (NDA)August 20, 2014
Jublia0187-5400SolutionNew drug applications (NDA)June 6, 2014
Retin-A MICRO0187-5148GelNew drug applications (NDA)January 28, 2014
Caladryl Clear0187-5466LotionOver the counter monograph drugsAugust 16, 2013
Caladryl0187-5465LotionOver the counter monograph drugsAugust 16, 2013
Noritate0187-5202CreamNew drug applications (NDA)August 9, 2013
Ativan0187-0065TabletNew drug applications (NDA)May 1, 2013
Ativan0187-0064TabletNew drug applications (NDA)May 1, 2013
Ativan0187-0063TabletNew drug applications (NDA)May 1, 2013
TheraSeal0187-1660CreamOver the counter monograph drugsJanuary 1, 2012
Cardizem LA0187-2050Tablet, extended releaseNew drug applications (NDA)December 25, 2010

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.